Package Leaflet: Information for the Patient
Rivaroxaban Zentiva 10 mg Hard Capsules EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Rivaroxaban Zentiva contains the active substance rivaroxaban and is used in adults to:
Rivaroxaban Zentiva belongs to a group of medications called antithrombotic agents. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Zentiva
Do not take Rivaroxaban Zentiva and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Rivaroxaban Zentiva.
Be careful with Rivaroxaban Zentiva
Tell your doctorif you have any of these conditionsbefore taking Rivaroxaban Zentiva. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery
Children and adolescents
Rivaroxaban Zentiva 10 mg hard capsules are not recommended for children under 18 years of age.There is not enough information about its use in children and adolescents.
Other medications and Rivaroxaban Zentiva
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those obtained without a prescription.
If any of the above circumstances apply to you,tell your doctorbefore taking Rivaroxaban Zentiva, as the effect of Rivaroxaban Zentiva may be increased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, they will recommend using a preventive treatment for ulcers in addition to Rivaroxaban Zentiva.
any medication for treating epilepsy (phenytoin, carbamazepine, phenobarbital)
St. John's Wort (Hypericum perforatum), a medicinal plant for treating depression
rifampicin, an antibiotic
If any of the above circumstances apply to you,tell your doctorbefore taking Rivaroxaban Zentiva, as the effect of Rivaroxaban Zentiva may be reduced. Your doctor will decide if you should be treated with Rivaroxaban Zentiva and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take Rivaroxaban Zentiva if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking Rivaroxaban Zentiva. If you become pregnant while taking this medication, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban Zentiva may cause dizziness (frequent side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). You should not drive or use machines if you are affected by these symptoms.
Rivaroxaban Zentiva contains lactose and sodium.
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially "sodium-free".
Follow the administration instructions of this medication exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
What dose to take
The recommended dose is one Rivaroxaban Zentiva 10 mg capsule once a day.
After at least 6 months of treatment for blood clots, the recommended dose is one 10 mg capsule once a day or one 20 mg capsule once a day. Your doctor has prescribed Rivaroxaban Zentiva 10 mg once a day.
Swallow the capsule preferably with water.
Rivaroxaban Zentiva can be taken with or without food.
If you have difficulty swallowing the capsule whole, consult your doctor about other ways to take Rivaroxaban Zentiva. The contents of the capsule can be mixed with water or apple sauce, immediately before taking it.
If necessary, your doctor may also administer the contents of the Rivaroxaban Zentiva capsule sprinkled through a gastric tube.
When to take Rivaroxaban Zentiva
Take the capsule every day, until your doctor indicates otherwise.
Try to take a capsule at the same time every day, to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the veins after hip or knee replacement surgery:
Take the first capsule 6 to 10 hours after surgery.
If you have undergone major hip surgery, you will usually take the capsules for 5 weeks.
If you have undergone major knee surgery, you will usually take the capsules for 2 weeks.
If you take more Rivaroxaban Zentiva than you should
Call your doctor immediately if you have taken too many Rivaroxaban Zentiva capsules. Taking too much Rivaroxaban Zentiva increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Rivaroxaban Zentiva
If you forget to take a dose, take it as soon as you remember. Take the next capsule the next day and, after that, take one capsule every day, as usual.
Do not take a double dose to make up for forgotten doses.
If you stop taking Rivaroxaban Zentiva
Do not stop taking Rivaroxaban Zentiva without talking to your doctor first, as Rivaroxaban Zentiva prevents the development of a serious condition.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, Rivaroxaban Zentiva can cause side effects, although not everyone will experience them.
Like other similar medications to reduce blood clot formation, Rivaroxaban Zentiva may cause bleeding, which can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be apparent.
Tell your doctor immediately if you experience any of the following side effects:
Your doctor will decide to keep you under closer observation or modify your treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequency of severe allergic reactions is very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data)
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on each blister after “EXP”. The expiry date refers to the last day of the month stated.
PVC/PVdC/Alu blisters: Store below 30 °C. Store in the original package to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Rivaroxaban Zentiva
Capsule content: lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, hypromellose, sodium laurilsulfate, and magnesium stearate.
Capsule shell: gelatin, titanium dioxide (E 171), yellow iron oxide (E 172), red iron oxide (E 172), and black iron oxide (E 172).
Black ink: shellac (E 904), black iron oxide (E 172), propylene glycol (E 1520), ammonia solution (E 527), and potassium hydroxide (E 525).
Appearance and Package Contents of the Product
Rivaroxaban Zentiva 10 mg capsules are a white to off-white powder filled in a size “3” capsule (15.9 ± 0.3 mm in length) with an opaque beige cap and body, printed with “10” in black ink on the cap.
The hard capsules are packaged in PVC/PVdC/Alu blisters.
Rivaroxaban Zentiva 10 mg is available in packs of 5, 10, 15, 20, 30, and 100 hard capsules.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Zentiva k.s.
U Kabelovny 130,
Dolní Mecholupy
102 37 Prague 10
Czech Republic
Manufacturer
Zentiva SA
B-dul Theodor Pallady nr. 50, sector 3,
Bucharest,
032266 Romania
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park,
Paola, PLA3000, Malta
For further information on this medicine, please contact the local representative of the Marketing Authorisation Holder:
Zentiva Spain S.L.U.
Avenida de Europa, 19, Edificio 3, Planta 1.
28224 Pozuelo de Alarcón, Madrid
Spain
This medicine is authorised in the Member States of the European Economic Area under the following names:
Czech Republic, Germany, and Italy: Rivaroxaban Zentiva
France: Rivaroxaban ZENTIVA
Portugal: Rivaroxabano Zentiva
Date of last revision of this leaflet:October 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es